A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

Clinical trial NCT06586112 · COMPLETED

Trial details

NCT number: NCT06586112
Sponsor: Alumis Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2024-07-25
Primary completion: 2025-09-19
Enrollment: 912

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.